Vertex Pharmaceutica
VRTX
Delayed Nasdaq - 09/22 10:00:00 pm
151.26USD
-0.53%
Prev.152.0600
Open151.5400
High152.0700
Low148.5801
Volume1 269 855
Last news
Financials
Sales 2017 2 294 M
EBIT 2017 494 M
R. net 2017 200 M
Tréso. 2017 642 M
Rend. 2017 -
P/E ratio 2017 218,02
P/E ratio 2018 89,42
EV / Sales 2017 16,3x
EV / Sales 2018 13,6x
Capitalization 38 136 M
Company
Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases.It focuses on development and commercializing therapies for the treatment of cystic fibrosis; infectious diseases, including...
Sector :
Bio Therapeutic Drugs
Calendar :
2017-10-31 Earnings Release
Trading Rating :
Investor Rating :
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralBullishBullish
Resistance162166163
Spread/Res.-6,8%-8,9%-7,3%
Spread/Supp.2,1%17%38%
Support148129110